Forever Living Revenue and Competitors

UK

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Forever Living's estimated annual revenue is currently $564.7M per year.(i)
  • Forever Living's estimated revenue per employee is $378,000

Employee Data

  • Forever Living has 1494 Employees.(i)
  • Forever Living grew their employee count by -1% last year.

Forever Living's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$28.1M10412%N/AN/A
#2
$35.9M1331%N/AN/A
#3
$74.3M2505%N/AN/A
#4
N/A0N/AN/AN/A
#5
$24M89-19%£8.2MN/A
#6
$8.6M40-9%N/AN/A
#7
$15.3M63-14%N/AN/A
#8
$182.3M5409%N/AN/A
#9
$182.3M54014%N/AN/A
#10
$148.5M4406%N/AN/A
Add Company

What Is Forever Living?

Heath and Nutrition Products with Royalty earning opportunity.\r\nNatural Aloe Vera Based Products Independently Distributed Forever Living Products.\r\nMaking a Real Difference to peoples lives by giving them the added opportunity of working in a fun environment at their own pace in difficult times with uncapped earning potential.

keywords:N/A

N/A

Total Funding

1494

Number of Employees

$564.7M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Forever Living News

2022-04-20 - Aloe Vera Market is Set to Develop New Growth Story | Evergreen ...

... Forever Living Products, Evergreen, Aloecorp, Terry Lab & Houssy. ... Swot Analysis for each profiled company [Forever Living Products,...

2022-04-20 - Aloe Vera Juice Market Size, Outlook And Forecast | OKF, ALO ...

... Outlook And Forecast | OKF, ALO, Keumkang B&F, Lotte Chilsung Beverage, Tulip, Medicaps, Aloe Farms, Forever Living Products, Houssy, AMB Wellness.

2022-04-19 - Aloe Vera Sales Market Size, Outlook And Forecast | Forever Living ...

Forever Living Products, Evergreen, Aloecorp, Terry Lab, Houssy. Aloe Vera Sales Market Segmentation: By the product type, the market is primarily split...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$531.3M149421%N/A
#2
$564.7M149459%N/A
#3
$35M14943%N/A
#4
$75M1496N/AN/A
#5
$75M14969%N/A